The effect of the combination of Lavandula angustifolia and Dracocephalum ruyschiana on mild to moderate depression

Evaluation of the therapeutic effect of combined Lavandula angustifolia and Dracocephalum ruyschiana extract on sertraline-treated mild to moderate depression patients.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200427047216N2

Enrollment

Registered

2020-07-04

Start date

2018-02-21

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression. Major depressive disorder, single episode, unspecified

Interventions

Intervention 1: Intervention group: Thirty-five people, who have diagnosed with depression by a specialist, received 100 mg of sertraline tablets and syrup containing two units of L. Angustifolia extr

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: the onset of disease in the last 6 months diagnosis of major depression with mild to moderate level.

Exclusion criteria

Exclusion criteria: neurological and physical disorders, mental disorders other than generalized anxiety disorder using medication in the past month

Design outcomes

Primary

Measure	Time frame
Depression. Timepoint: Evaluation of the rate of depression with a "back test (BDI)" at the beginning of the study and 60 days after taking the syrup containing the extracts. Method of measurement: The Beck Depression Inventory (BDI) questionnaire was used for evaluation of the effects of the intervention. This scale is one of the most valid diagnostic tools for depression whose validity and reliability have been confirmed in various studies.	—

Measure

Time frame

Depression. Timepoint: Evaluation of the rate of depression with a "back test (BDI)" at the beginning of the study and 60 days after taking the syrup containing the extracts. Method of measurement: The Beck Depression Inventory (BDI) questionnaire was used for evaluation of the effects of the intervention. This scale is one of the most valid diagnostic tools for depression whose validity and reliability have been confirmed in various studies.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTabriz University of Medical Sciences

Tabriz University of Medical Sciences

khalili876@gmail.com+98 41 3337 8093

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026